4.7 Article

Tespa1 facilitates hematopoietic and leukemic stem cell maintenance by restricting c-Myc degradation

期刊

LEUKEMIA
卷 -, 期 -, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41375-023-01880-6

关键词

-

向作者/读者索取更多资源

This study reveals that Tespa1 is important for the maintenance of hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) and plays a crucial role in HSC and LSC self-renewal. Tespa1 prevents degradation of c-Myc protein in HSCs and is essential for AML cell growth. Tespa1 deficiency suppresses leukemogenesis and LSC maintenance.
Hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) have robust self-renewal potential, which is responsible for sustaining normal and malignant hematopoiesis, respectively. Although considerable efforts have been made to explore the regulation of HSC and LSC maintenance, the underlying molecular mechanism remains obscure. Here, we observe that the expression of thymocyte-expressed, positive selection-associated 1 (Tespa1) is markedly increased in HSCs after stresses exposure. Of note, deletion of Tespa1 results in short-term expansion but long-term exhaustion of HSCs in mice under stress conditions due to impaired quiescence. Mechanistically, Tespa1 can interact with CSN subunit 6 (CSN6), a subunit of COP9 signalosome, to prevent ubiquitination-mediated degradation of c-Myc protein in HSCs. As a consequence, forcing c-Myc expression improves the functional defect of Tespa1-null HSCs. On the other hand, Tespa1 is identified to be highly enriched in human acute myeloid leukemia (AML) cells and is essential for AML cell growth. Furthermore, using MLL-AF9-induced AML model, we find that Tespa1 deficiency suppresses leukemogenesis and LSC maintenance. In summary, our findings reveal the important role of Tespa1 in promoting HSC and LSC maintenance and therefore provide new insights on the feasibility of hematopoietic regeneration and AML treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据